Company news: ECS Botanics; Althea; InhaleRx; Neurotech International by Martin Lane and Steve Jones July 10, 2024July 11, 2024 ECS Botanics is set to expand its medicinal cannabis product line after receiving a government manufacturing […]
ECS Botanics prepares for ‘massive shift’ towards retail strategy by Steve Jones May 29, 2024May 30, 2024
ECS strikes A$380k deal as firm launches direct-to-consumer sales by Steve Jones May 20, 2024May 23, 2024
ECS Botanics founder Alex Keach sells 50m shares and steps down from the board by Steve Jones May 6, 2024May 7, 2024
Record harvest and softer revenue hit ECS Botanics’ Q3 cash flow by Steve Jones April 29, 2024April 29, 2024
Local firms call for united voice to tackle import-export disparity as Australia is branded a cannabis ‘honeypot’ by Steve Jones March 27, 2024March 27, 2024
Launch of consumer strategy ‘not taken lightly’, as ECS Botanics looks to capitalise on ‘unique IP’ by Steve Jones March 11, 2024March 11, 2024
German legalisation set to ‘open up opportunities’ for Australian firms by Steve Jones February 29, 2024July 16, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024July 16, 2024
ECS Botanics chases in-house product growth after A$4m capital raise by Steve Jones February 22, 2024February 22, 2024
